First Hawaiian Bank Medpace Holdings, Inc. Transaction History

First Hawaiian Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 02, 2024	SELL	$372.0 - $424.34 $254,820 - $290,672	-685 Reduced 23.04%	2,288 $942,000
Q1 2024 Apr 05, 2024	BUY	$284.87 - $413.31 $34,754 - $50,423	122 Added 4.28%	2,973 $1.2 Million
Q4 2023 Jan 08, 2024	BUY	$227.52 - $312.68 $51,192 - $70,353	225 Added 8.57%	2,851 $873,000
Q2 2023 Jul 06, 2023	BUY	$187.26 - $240.17 $2,059 - $2,641	11 Added 0.42%	2,626 $630,000
Q1 2023 Apr 18, 2023	SELL	$174.31 - $239.52 $229,217 - $314,968	-1,315 Reduced 33.46%	2,615 $491,000
Q4 2022 Jan 12, 2023	SELL	$153.06 - $226.57 $67,346 - $99,690	-440 Reduced 10.07%	3,930 $835,000
Q3 2022 Oct 05, 2022	BUY	$145.13 - $182.49 $634,218 - $797,481	4,370 New	4,370 $687,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.